Pfizer Inc. buy Guggenheim
Start price
23.02.24
/
50%
€25.55
Target price
23.02.25
€33.22
Performance (%)
-1.84%
End price
24.02.25
€25.08
Summary
This prediction ended on 24.02.25 with a price of €25.08. With a performance of -1.84%, the BUY prediction for Pfizer Inc. by Guggenheim closed slightly in the red. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. A total of €1.58 was paid as dividends for this prediction. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 1.433% | 1.433% | -19.243% |
| iShares Core DAX® | -0.081% | -1.435% | 28.742% |
| iShares Nasdaq 100 | -0.201% | 1.543% | 3.702% |
| iShares Nikkei 225® | 1.465% | 1.838% | 2.749% |
| iShares S&P 500 | 0.215% | 1.237% | 4.241% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten